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Neuronal Lewy body-like hyaline inclusions (LBHI) and astrocytic hyaline inclusions (Ast-HI) containing mutant Cu/Zn
superoxide dismutase 1 (SOD1) are morphological hallmarks of familial amyotrophic lateral sclerosis (FALS) associated with
mutant SOD1. However, the mechanisms by which mutant SOD1 contributes to formation of LBHI/Ast-HI in FALS remain poorly
defined. Here, we report induction of LBHI/Ast-HI-like hyaline inclusions (LHIs) in vitro by ER stress in neuroblastoma cells.
These LHI closely resemble LBHI/Ast-HI in patients with SOD1-linked FALS. LHI and LBHI/Ast-HI share the following features: 1)
eosinophilic staining with a pale core, 2) SOD1, ubiquitin and ER resident protein (KDEL) positivity and 3) the presence of
approximately 15–25 nm granule-coated fibrils, which are morphological hallmark of mutant SOD1-linked FALS. Moreover, in
spinal cord neurons of L84V SOD1 transgenic mice at presymptomatic stage, we observed aberrant aggregation of ER and
numerous free ribosomes associated with abnormal inclusion-like structures, presumably early stage neuronal LBHI. We
conclude that the LBHI/Ast-HI seen in human patients with mutant SOD1-linked FALS may arise from ER dysfunction.
Citation: Yamagishi S, Koyama Y, Katayama T, Taniguchi M, Hitomi J, et al (2007) An In Vitro Model for Lewy Body-Like Hyaline Inclusion/Astrocytic
Hyaline Inclusion: Induction by ER Stress with an ALS-Linked SOD1 Mutation. PLoS ONE 2(10): e1030. doi:10.1371/journal.pone.0001030
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegen-
erative disorder in which both upper and lower motor neurons
begin to degenerate in middle-aged persons. About 10% of ALS
patients demonstrate autosomal dominant inheritance of this
disease, a disorder known as familial ALS (FALS) [1–6]. About
20% of FALS cases are associated with mutations of the Cu/Zn-
superoxide dismutase (SOD1) gene [7]. SOD1 is an abundant
protein of approximately 153 amino acids that accounts for
approximately 1% of total cytosolic protein. More than 100
different SOD1 mutations have been reported as risk factors in
association with FALS.
The endoplasmic reticulum (ER) is responsible for the synthesis,
initial post-translational modification, and proper folding of
proteins, as well as for their sorting export and delivery to
appropriate cellular destinations. A variety of conditions, such as
loss of the intraluminal oxidative environment or loss of calcium
homeostasis, can cause accumulation of misfolded proteins in the
ER. To cope with such accumulation, there are three possible
responses in eukaryotes. The first response is known as the
unfolded protein response (UPR), in which IRE1a and ATF6
recognize aberrant proteins and increase the expression of ER-
resident chaperones such as GRP78/BiP and GRP94 to promote
proper protein folding [8,9]. The second response involves
suppression of translation mediated by the serine/threonine kinase
PERK, which phosphorylates and inactivates the translation
initiation factor eIF-2a to reduce the production of misfolded
proteins [10,11]. The third response is ER-associated degradation
(ERAD), in which misfolded proteins are expelled from the ER
and targeted for degradation by cytoplasmic proteasomes [12,13].
Although these three protective responses can transiently control
the accumulation of misfolded proteins within the ER, they can be
overcome by sustained ‘ER stress’ [14–16]. ‘ER stress’ is involved
in neuronal death and various neurodegenerative disorders, such
as Charcot-Marie-Tooth disease, and is especially related to
inclusion body diseases such as Alzheimer’s disease, Parkinson’s
disease, Huntington’s disease and ALS [17–23].
Histopathologic studies have revealed that neuronal Lewy body-
like hyaline inclusions (LBHI) and astrocytic hyaline inclusions
(Ast-HI), are morphological hallmarks of mutant SOD1-linked
FALS [24]. Neuronal LBHI and Ast-HI are ultrastructually
identical and share various features, with both consisting of 15–
25 nm granule-coated fibrils, both showing immunoreactivity for
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both appearing late in the course of the disease (i.e. at ,10 to
30 years of age in humans [24–27]). Recently, Wate et al. reported
that neuronal LBHI are immunoreactive for GRP78/BiP,
a component of the UPR cellular response to ER stress [28].
In the present study, we show that ER stress in a neuroblastoma
line expressing mutant SOD1 can provoke SOD1 aggregation in
ER and formation of LBHI/Ast-HI-like hyaline inclusion bodies
(LHIs), which show SOD1, ubiquitin, GRP78/BiP and ER
resident protein (KDEL) immunopositivity similar to the shared
cytopathological features of LBHI and Ast-HI. Induced neuro-
blastoma LHI furthermore consisted of 15–25 nm granule-coated
fibrils, a hallmark of mutant SOD1-linked FALS, raising the
possibility that these acutely induced aggregations represent
a precursor to LBHI/Ast-HI seen in advanced FALS. In support
of this possibility, we observe abnormal ER and numerous free
ribosomes aggregated in the peri-nuclear region neuroblastoma
cells expressing L84V SOD1 under ER stress condition and in
spinal cord neurons in presymptomatic transgenic mice expressing
L84V SOD1. Taken together, these findings suggest a model for
early events in FALS cellular pathology, in which ER stress
promotes the aggregation of mutant SOD1 and is involved in the
development of LBHI/Ast-HI in patients with mutant SOD1
linked FALS.
RESULT
Aggregation and ubiquitination of mutant SOD1
under ER stress
To identify conditions which lead to the aggregation of mutant
SOD1, we generated SK-N-SH human neuroblastoma cell lines
that stably expressed FLAG-tagged human SOD1 encoding
a leucine to valine substitution mutation (L84V) associated with
FALS [29]. Western blot analysis confirmed that expression of
endogenous and exogenous SOD1 was equal in the cell line
(Fig. 1A). Reports that neuronal LBHI contain GRP78/BiP, an
ER resident component of the UPR response, suggested that ER
stress might be a factor in the aggregation of mutant SOD1 [28].
We therefore examined localization of wild-type and mutant
SOD1 under normal conditions and under conditions of ER stress
(Figure 1). Under normal conditions, wild-type and L84V SOD1
were distributed through the cytosol (Fig. 1B and D). However,
following treatment with tunicamycin, an inhibitor of N-
glycosylation which causes ER stress, small SOD1-positive
aggregates (up to 3 mm in diameter) were seen in L84V SOD1-
expressing cells (22.3%, p,0.001; Fig. 1E and F). A much smaller
percentage of wild-type SOD1 expressing cells (2.9%, n.s.) showed
non-inducible SOD1 aggregation (Fig. 1C and F). To confirm
whether ER stress is required for the aggregation of SOD1, we
compared tunicamycin and thapsigargin as ER stress inducers
with etoposide as a non-ER stress inducer (causing DNA damage).
Exposure to 1 and 3 mg/ml tunicamycin (21.1% and 17.5%,
respectively) or 0.3 and 1 mM thapsigargin (27.0% and 27.2%,
respectively) significantly increased the number of cells containing
SOD1 aggregates, in L84V SOD1 expressing neuroblastoma cells.
Treatment with 100 and 300 mM etoposide did not lead to
a significant increase in aggregates (Fig. 1G). Thus mutant SOD1
forms aggregates following treatments provoking ER stress, but
not following treatment causing damage to the nucleus.
Since the SOD1-positive inclusions of FALS patients are known
to be eosinophilic [26], we performed hematoxylin-eosin (HE) and
anti-SOD1 antibody staining to determine whether the aggregates
induced in the neuroblastoma line were also eosinophilic.
Figure 1. Eosinophilic aggregates of L84V SOD1 are induced by ER
stress. (A) Western blotting analysis of the expression of SOD1 in SK-N-
SH cells, which stably expressed FLAG tagged wild-type SOD1 or L84V
mutant SOD1. Arrowheads and arrow indicate exogenous and
endogenous SOD1, respectively. (B–D) Immunofluorescent analysis of
SOD1 aggregates in SK-N-SH cells expressing wild-type SOD1 (B, C)o r
L84V SOD1 (D, E). Cells were incubated under control conditions (B, D)
or with 1 mg/ml tunicamycin (C, E) for 24 h, and then were fixed and
stained with an anti-SOD1 antibody. Tunicamycin induced aggregates
of SOD1 (arrowheads) in L84V SOD1-expressing cells, but not in wild-
type SOD1-expressing cells. Scale bar=20 mm. (F) Quantification of (B-
D). After the staining the cells with SOD1 aggregates were counted and
scored. Numbers indicate the amounts of total counted cells. Asterisks
show a significant difference from control, *p,0.001. (G)S O D 1
aggregates induced by tunicamycin and thapsigargin, but not by
etoposide. SK-N-SH cells expressing L84V SOD1 were exposed to 0.3, 1
and 3 mg/ml tunicamycin, 0.3 and 1 mM thapsigargin and 100 and
300 mM etoposide. Asterisks show a significant difference from control,
*p,0.001. (H-J) Eosinophilic SOD1 aggregates induced by tunicamycin.
Cells were treated as described in (E) and then stained with HE (H), anti-
SOD1 antibody (I), or both (J). Scale bar=20 mm.
doi:10.1371/journal.pone.0001030.g001
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treatment were positive for both eosin and SOD1.
In patients with mutant SOD1-linked FALS, SOD1-positive
aggregates are reported to be ubiquitinated by RING finger-type
E3 ubiquitin ligases such as dorfin [30–33]. To investigate whether
the SOD1 aggregates induced by ER stress were ubiquitinated, we
performed double immunostaining with anti-SOD1 and anti-
ubiquitin antibodies (Fig. 2 A–R). After treatment with either
tunicamycin or ALLN, a specific proteasome inhibitor, wild-type
and L84V SOD1-expressing cells were immunostained with anti-
SOD1 and anti-ubiquitin antibodies. As a result, mutant SOD1
aggregates induced by either tunicamycin or ALLN were clearly
colocalized with ubiquitin, suggesting the SOD1 were ubiquiti-
nated. To further examine the ubiquitination of the mutant
SOD1, a co-immunoprecipitation assay utilizing ubiquitin was
performed (Fig. 2S). As expected, L84V SOD1-expressing cells
showed a positive ubiquitin ladder after ALLN treatment, but
wild-type SOD1-expressing cells did not.
Aggregates of SOD1 show positive localization to
the ER, but not to the mitochondria, lysosomes, or
Golgi apparatus
Under normal conditions, SOD1 is diffusely distributed through-
out the cytoplasm. In contrast, under the pathological condition,
SOD1 aggregates are associated with specific organelles such as
the mitochondria and/or ER [34–37]. Since the tunicamycin-
induced aggregates of mutant SOD1 were localized to the central
and peripheral regions of the cytoplasm (Fig. 1E, H–J), we
investigated the subcellular localization of these aggregates with
organelle specific markers. Confocal microscopy analysis clearly
showed colocalization of SOD1 and an ER retention signal
Figure 2. Ubiquitination of mutant SOD1 aggregates. (A–R) Colocalization assay with SOD1 and ubiquitin. SK-N-SH cells expressing wild-type SOD1
(A–I) or L84V SOD1 (J–R) were incubated with 1 mg/ml of tunicamycin (D–F, M–O), 4 mg/ml of ALLN (G–I, P–R), or no agents (A–C, J–L) for 24 h. Then
the cells were fixed and stained with anti-SOD1 antibody (green; A, D, G, J, M, P) or anti-ubiquitin antibody (red; B, E, H, K, N, Q). Arrows indicate
colocalization of SOD1 aggregates and ubiquitin. Scale bar=20 mm. (S) Co-immunoprecipitation assay utilizing ubiquitin. SK-N-SH cells stably
expressing wild-type and L84V SOD1 were transfected with a myc-tagged ubiquitin expression vector. After incubation with or without ALLN, cell
lysates were prepared and assayed with anti-myc antibody of the immunoprecipitant with anti-FLAG antibody. Asterisk shows an ubiquitinated
ladder that appeared after ALLN treatment of L84V SOD1-expressing cells. IgG bands are shown as loading controls.
doi:10.1371/journal.pone.0001030.g002
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PLoS ONE | www.plosone.org 3 October 2007 | Issue 10 | e1030Figure 3. Positive translocation of SOD1 aggregates to ER, but not to the mitochondria, Golgi apparatus, or lysosomes. (A–I, A9–I9) Stress-
dependent localization of SOD1 to the ER. L84V SOD1-expressing SK-N-SH cells were incubated for 24 h without (A–I) or with 1 mg/ml of tunicamycin
(A9–I9). Then the cells were fixed and stained using an anti-SOD1 antibody (green; A, D, A9,D 9) and an anti-KDEL antibody (red; B, B9) or an anti-
GRP78/BiP antibody (red; E, E9). GFP-cytochrome b5 were transfected to the cells and stained with anti-GFP (green; G, G9) and anti-SOD1 (red; H, H9)
antibodies. Merged images (C, F, I, C9 F9,I 9). The aggregates of SOD1 (arrowheads) are positive for KDEL, GRP78/BiP and cytochrome b5. (J–R, J9–R9)
Analysis of SOD1 localization to the mitochondria. L84V SOD1-expressing SK-N-SH cells were treated as described in above. The locations of the
mitochondria and SOD1 were visualized in L84V SOD1-expressing SK-N-SH cells using 100 nM Mito-tracker (red; K, K9), an anti-Tim17 antibody (red; N,
N9) or an anti-Tom20 antibody (red; Q, Q9) and an anti-SOD1 antibody (green; J, M, P, J9,M 9,P 9). Merged images (L, O, R, L9,O 9,R 9). (S–U, S9–U9)
Investigation of SOD1 localization to the Golgi apparatus. L84V SOD1-expressing SK-N-SH cells were treated as described in above. Then the cells
were stained with anti-SOD1 antibody (green; S, S9) and anti-GM130 antibody (red; T, T9). Merged images (U, U9). (V-X, V9-X9) Analysis of the
localization of SOD1 to the lysosomes. A GFP-tagged L84V SOD1 vector was transfected into L84V SOD1-expressing SK-N-SH cells. After 24 h of
incubation with 1 mg/ml of tunicamycin, the cells were incubated for a further 30 min with 100 nM Lyso-tracker (red; W, W9) to visualize the
lysosomes. GFP channel (V, V9) Merged images (X, X9). Scale bars=20 mm. Arrowheads indicate aggregated SOD1.
doi:10.1371/journal.pone.0001030.g003
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localization in ER (Fig. 3A–F, A9–F9). In order to confirm the
SOD1 colocalization with ER, we utilized GFP conjugated
cytochrome b5, a typical C-terminal anchored ER membrane
protein. As expected, SOD1 showed the positive staining with
cytochrome b5, indicating mutant SOD1 localization to ER
(Fig. 3G–I, G9–I9). In the absence of stress, ER was located to the
perinuclear region. However, treatment with tunicamycin seemed
to cause its relocation to an abnormal region near the cell
periphery. The aberrant distribution of ER following tunicamycin
treatment was not observed in cells expressing wild type SOD1
(Fig. S1C9,F 9 and I9). These results suggest deterioration of ER
function and localization due to aggregation of mutant SOD1.
In light of previous reports identifying mutant SOD1 coloca-
lization to the mitochondria [34,35,37], we also examined the
potential colocalization of mutant SOD1 with mitochondria. In
contrast to the results with markers for ER, the SOD1 aggregates
induced by tunicamycin did not colocalize with the mitochondria
marker Mitotracker, with Tim17 which marks the mitochondrial
inner membrane nor Tom20 which marks the mitochondrial outer
membrane (Fig. 3J9–R9). The localization of these SOD1
aggregates also did not correspond with the Golgi apparatus or
the lysosomes, which were stained by anti-GM130 antibody and
Lyso-tracker, respectively (Fig. 3S9–X9).
Our previous results in figure 3C9,F 9 and I9 revealed aberrant
redistribution of ER membranes in tunicamycin-treated mutant
SOD1 expressing cells to the cell periphery region. To directly
visualize the localization of ER, we performed electron micro-
scopic analysis of tunicamycin-stressed cells expressing mutant
SOD1. Figure 4A and B showed abnormal aggregates of rough
ER, sac-like structures with surface ribosomes, associated with
numerous free ribosomes. Mutant SOD1 localization to these
peripheral aggregates was confirmed by immunoelectron micros-
copy (Fig. 4C), implying defective functional activities of ER and
free ribosomes in cells expressing mutant SOD1.
LBHI/Ast-HI-like Inclusions are induced by ER stress.
Wate et al. [28] reported that neuronal LBHI in G93A SOD1
transgenic mice are immune reactive for GRP78/BiP, an ER
resident component of the UPR response. As shown in figures 3A9-
I9 and 4C, mutant SOD1 localized to the ER following stress
induction by tunicamycin. These SOD1 aggregates shared
additional features with LBHI/Ast-HI, namely eosin positivity
and ubiquitin immune reactivity. Those observations led us to
consider whether ER stress would eventually induce the formation
of full-fledged LBHI/Ast-HI. To test this hypothesis, we examined
whether inclusion bodies containing mutant SOD1 developed in
L84V SOD1-expressing cells subjected to ER stress. Consistent
with this idea, eosinophilic hyaline inclusions (,10 to 20 mmi n
diameter) with a pale core, which are similar to neuronal LBHI/
Ast-HI in the spinal cord of ALS patients harboring a SOD1
mutation, developed within 24 hrs of exposure to tunicamycin
(Fig. 5A), but not in cells expressing wild type SOD1 (data not
shown). In fact, the eosin-positive LBHI/Ast-HI-like hyaline
inclusions (LHIs) were morphologically similar to the Ast-HI seen
in the spinal cord of transgenic L84V SOD1 mice at the
symptomatic stage (Fig. 5A and D). Furthermore, ultrastructual
analysis revealed that the LHIs in neuroblastoma cells were
composed of granule-coated fibrils (approximately 15–25 nm in
diameter) and granular materials, which are the typical morpho-
Figure 4. ER and SOD1 co-localization in peri-cytoplasmic membrane
region. (A) Electron micrograph of L84V SOD1-expressing SK-N-SH cells
after treatment with 1 mg/ml of tunicamycin for 24 h as described in
Materials and Methods. (B) Enlargement of part of (A). Arrowheads
indicate abnormal ER aggregates, where mutant SOD1 is localized as in
Fig. 3C9 and 3E9. Scale bar=1 mm. (C) SOD1 localization in peri-
cytoplasmic membrane region. Cells were treated as described in (A)
and immune electron micrograph was obtained as described in
Materials and Methods. Arrows show SOD1 immunoreactive in ER.
doi:10.1371/journal.pone.0001030.g004
Figure 5. LHIs containing granule-coated fibrils are morphologically
identical with Ast-HI from L84V transgenic mice. (A–F) Comparison of
a LHI induced by ER stress in an L84V SOD1-expressing SK-N-SH cell (A–
C) and Ast-HI in the spinal cord of a transgenic L84V SOD1 mouse (D–F).
(A) An eosinophilic LHI in the cytoplasm of the SK-N-SH cell expressing
L84V SOD1 cell was induced by treatment with 1 mg/ml of tunicamycin
for 24 h (scale bar=20 mm). (B) Electron micrograph of a hyaline
inclusion (arrow) obtained by the direct epoxy resin-embedding
method after decolorization of the HE-stained section shown in (A).
N, nucleus; 63000 (scale bar=1 mm). (C) At a high magnification, the
inclusion is composed of granule-coated fibrils (arrows) approximately
15–25 nm in diameter and granular materials. 616000 (scale
bar=1 mm). (D) An eosinophilic Ast-HI from a transgenic L84V SOD1
mouse. (E) Electron micrograph of an Ast-HI obtained by the direct
epoxy resin-embedding method mentioned in (B). N, nucleus; 62000
(scale bar=1 mm). (F) Enlargement of (E). 616000 (scale bar=1 mm).
Note that the fibrils observed in (C) and (F) are ultrastructually identical.
doi:10.1371/journal.pone.0001030.g005
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identical with the Ast-HI found in L84V SOD1 mice (Fig. 5C,
F; [38]). These results suggest that LBHI/Ast-HI in FALS patients
might be provoked by ER stress as we observed for LHIs.
We further explored the molecular similarity between the LHI
and LBHI/Ast-HI, using double-label immunocytochemistry. As
shown in figure 6A–D, LHIs induced by tunicamycin are
immunopositive for anti-SOD1 and anti-ubiquitin antibodies,
consistent with the LBHI/Ast-HI features. In the spinal cord
of G93A SOD1 mutant mice at the symptomatic stage,
neuronal LBHI show GRP78/BiP immunoreactive, suggesting
the involvement of ER resident protein [28]. Therefore, we
examined whether LHIs also contain ER resident protein. As
expected, LHI showed anti-KDEL positivity, indicating the
involvement of ER resident proteins such as calreticulin, GRP
94, PDI and GRP78/BiP in LHI development (Fig. 6E and F).
Furthermore, Ast-HI in spinal cord of L84V SOD1 transgenic
mice at symptomatic stage also showed KDEL positive (Fig. 6G
and H), meaning that the principle features of these inclusions in
neuroblastoma cells and the LBHI/Ast-HI of FALS patients are
the same and implying LHI and LBHI/Ast-HI might develop in
similar procedure.
Abnormal ER aggregated around peri-nuclear
region with numerous free ribosomes at
presymptomatic stage of Ast-HI in L84V SOD1 mice.
To further explore the relationship of LHI to the development of
LBHI/Ast-HI in FALS patients with mutant SOD1, we
performed ultrastructual examination of transgenic L84V SOD1
mice, which show neuronal LBHI and Ast-HI at symptomatic
stage (Fig. 5D–F, 6G–H; [35]). We examined the mice at the
presymptomatic stage in the hope of detecting precursors to
hyaline inclusion bodies. In spinal cord neurons of the pre-
symptomatic L84V SOD1 transgenic mice, we observed aberrant
aggregation of electron-dense rough ER around the peri-nuclear
region with numerous free ribosomes, which were suspected to be
producing mutant SOD1 (Fig. 7). This suggests that the aberrant
SOD1 fibrils observed in spinal neurons of these mice at later
Figure 7. ER shows abnormal aggregation with numerous free
ribosomes in L84V SOD1 mouse at presymptomatic stage. (A–C)
Electron micrographs of a neuron obtained from an L84V SOD1
transgenic mouse containing ER aggregates. The inset in (A) shows a
cytoplasmic inclusion-like structure (arrowhead) stained with toluidine
blue. (A) 63500 (scale bars=20 mm). (B) 68000 (scale bar=1 mm).
(C) 615000 (scale bar=1 mm). Arrowheads indicate abnormal ER
aggregates.
doi:10.1371/journal.pone.0001030.g007
Figure 6. Positive immunoreactive against ubiquitin, SOD1 and KDEL
of LHIs. (A–D) LHIs show immunoreactive against ubiquitin and SOD1.
Eosinophilic LHIs in SK-N-SH cells (arrowheads in A and C) induced by
tunicamycin were immunostained for ubiquitin (B) and SOD1 (D) after
de-colorization. (E–H) KDEL immunoreactive in both LHI and Ast-HI.
Eosinophilic LHI in SK-N-SH cells (arrowhead in E) and Ast-HI in spinal
cord of L84V SOD1 mouse (arrowhead in G) were immunostained
against anti-KDEL antibody after de-colorization (F, H). Scale
bar=20 mm
doi:10.1371/journal.pone.0001030.g006
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ribosomes. These inclusion-like structures with abnormal accu-
mulation of ER seemed likely to represent a precursor to the later
neuronal LBHI observed in this line. These results imply that the
deterioration of ER function and the involvement of ER might be
important for formation and developing neuronal LBHI/Ast-HI
in mutant SOD1 harboring FALS patients.
DISCUSSION
Aggregated proteins or inclusions are a pathological hallmark and
possible causative agent of several neurodegenerative disorders
including ALS [39]. While LBHI/Ast-HI have been established as
morphological hallmarks of mutant SOD1-linked FALS, little is
known about the formation of these structures in neurons [6].
Several in vitro systems have been provided for analysis mutant
SOD1 aggregation [35,36,40], however, the relationship between
mutant SOD1 aggregation in vitro and pathological hyaline
inclusions in vivo remains unclear. The LHI we observed in SK-
N-SHcells expressing mutant SOD1 providea directlinkbetween in
vitro and in vivo SOD1 aggregation. To our knowledge, this is the first
studytoshowreproducibleinductionofLBHI/Ast-HIlikestructures
meeting the criteria of inclusion bodies [24,26,31,38,41].
LBHIs/Ast-HIs in human FALS consist of a chaotic mixture of
cytoplasmic proteins (such as SOD1, copper chaperone for SOD
(CCS), peroxiredoxin 2, and glutathione peroxidase 1), cytoskeletal
proteins (such as tubulin, tau protein, and phosphorylated- and
nonphosphorylated neurofilament), nuclear proteins (such as
neuron-specific enolase) and synaptic proteins (such as synapto-
physin [24,38,41–43]). Recently, it has been published that
GRP78/BiP, an ER resident chaperon protein, is also co-localized
with LBHI of G93A SOD1 mice [28]. GRP78/BiP is molecular
chaperone protein induced by IRE1 in response to aberrant
protein folding and promotes proper protein folding. In this
context, GRP78/BiP may be acting as part of the UPR response
to resolve granule coated fibrils. Tobisawa et al. [35] reported
increased protein levels of GRP78/BiP in motor neurons of
mutant SOD1 transgenic mice, suggesting that the motor neurons
in their model suffer from ‘ER stress’. While the importance of ER
stress or proteosome malfunction in formation of mutant SOD1
aggregates has been established [35,36,40], the mechanisms by
which mutant SOD1 forms LBHI/Ast-HI in FALS remain poorly
understood. In this study, we present three lines of evidence for the
involvement of ER stress in early events in LBHI/Ast-HI
formation. First, ER stress in neuroblastoma cells expressing
mutant SOD1 results in SOD1- and ubiquitin-immunopositive
LHIs, compatible with LBHI/Ast-HI, composed of granule-coated
fibrils approximately 15–25 nm in diameter and granular
materials (Figs. 5 and 6). Secondly, we observed similar structures
in the spinal cord of L84V SOD1 transgenic mice at pre-
symptomatic stages, including abnormal electron dense, i.e.
stressed, ER and numerous free ribosomes. (Figs. 4 and 7). Third,
positive staining against anti-KDEL antibody, which recognizes
ER resident proteins such as calreticulin, GRP 94, PDI and
GRP78/BiP, were observed in both the LHI and Ast-HI of L84V
SOD1 transgenic mice at symptomatic stages (Fig. 6E–H). These
findings support the hypothesis that ER stress induces LBHIs/Ast-
HIs creation in FALS patients with mutant SOD1. Taken
together, these observations suggest that LHI in neuroblastoma
cells and LBHI/Ast-HI in FALS patients might develop through
similar processes.
In this study, we presented evidences that ER stress causes
aggregates of mutant SOD1 and formation of LHI which is
compatible with LBHI/Ast-HI. However, other questions arise
from these results. 1) Why did same stress induce the different
outcome of mutant SOD1 aggregation in the neuroblastoma? 2)
Are the smaller aggregates competent to develop to LHIs? To
answer these questions, we sought without success to identify the
origin of the granule coated fibrils or SOD1 containing
filamentous structure (e.g. less densely coated fibrils) in the smaller
SOD1 aggregates localized to ER in L84V SOD1 expressing cells.
Nevertheless, we found common features between the small
aggregates in L84V SOD1 expressing SK-N-SH cells and neuronal
LBHI-precursor in L84V transgenic mice, including regions of
abnormal ER aggregation surrounded by abundant free ribosomes
(Fig. 4B and Fig 7C). Furthermore, LHI and Ast-HI were
immunopositive for the KDEL peptide present in ER-resident
proteins, suggesting the involvement of ER itself in formation or
developmentofLBHI/Ast-HI(Fig.6E–H).Wesuggestthat aberrant
SOD1 fibril might be produced by cooperative activity of ER and
ribosomes. To answer the questions, careful observation of LHI with
time lapse analysis is needed.
It remains unclear why the major symptoms of ALS in patients
with mutant SOD1-linked FALS do not develop until middle age,
but we speculate that age-dependent changes in responses to ER
stress might provide an answer. Under normal conditions, newly
synthesized and misfolded proteins are refolded by chaperons such
as GRP78, 94, calnexin, and calreticulin. This UPR response may
be more robust in younger FALS patients and might be the reason
the proteins aggregates are not observed in young patients even
though mutant SOD1 is expressed. However, a decrease in
protein folding or chaperone capability may occur with aging, and
accumulation of misfolded proteins in the ER lumen may
gradually lead to ER stress [44]. Consistent with this idea,
Tobisawa et al. reported mutant SOD1 retention in the ER in
COS7 cells [35] and Kikuchi et al. reported age-dependent
increase of mutant SOD1 aggregation to ER in spinal cord of
G93A SOD1 mice, suggesting ER dysfunction might be caused by
mutant SOD1 [36]. Prolonged ER stress associated with in-
sufficient degradation of misfolded proteins would subsequently
activate apoptotic pathways. Nakagawa et al. reported that
caspase-12, the ER resident caspase, is specifically cleaved and
activated by ER stress, and that cells derived from mice lacking
caspase-12 are resistant to ER stress [16]. In the spinal cords of
G93A SOD1 mice, caspase-12 is activated in symptomatic period
and can be inhibited by overexpression of XIAP (X-linked
inhibitor of apoptosis protein [45,46]. Then, we analyzed
activation of caspase-4 (the human orthologue of rodent caspase-
12) following tunicamycin treatment. As expected, the SOD1
aggregates of the L84V SOD1-expressing neuroblastoma cells
colocalized with caspase-4 (unpublished data), implying caspase-4
might contribute to cell death in our model system.
Although it can take longer than 30 years for LBHI/Ast-HI to
develop in FALS patients, we could induce the formation of
morphologically similar LHI within 24 hours in our simple model.
Detection of the molecular targets for ER stress-induced hyaline
inclusions of mutant SOD1 in our model might lead to the
development of therapy that can prevent the progression of mutant
SOD1-linked FALS. Ultimately, our study should contribute to the
development of a simple system to analyze novel therapies for ALS.
MATERIALS AND METHODS
Transgenic Mice
Transgenic mice for mutant human SOD1
L84V (C587BL/6
background) were created (M. Kato, et al. Transgenic mice with
ALS-linked SOD1 mutant L84V. Abstract of the 31st Annual
Meeting of Society for Neuroscience, San Diego, 2001). Mice were
genotyped by PCR to detect the mutant SOD1 transgene using
LBHI/Ast-HI-Like Inclusions
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GATTA; reverse, GCTAGCAGGATAACAGATGA. The onset
of symptoms was at 5–6 months and the initial sign of the disease
was usually weakness in their hindlimbs, while approximately 10%
of the mice first showed weakness in their forelimbs.
Chemicals and antibodies
We used the following antibodies: anti-SOD1 polyclonal antibody
(pAb; Chemicon, Temecula, CA); anti-ubiquitin pAb and anti-
KDEL mAb (Stressgen, Victoria, BC. Canada); anti-Tim17 pAb
and anti-Tom20 pAb (grateful gifts by Dr. Otera and Prof. Mihara
[47,48]); Alexa Fluor 488-conjugated anti-sheep IgG, Alexa Fluor
588-conjugated anti-mouse IgG antibody, and Alexa Fluor 588-
conjugated anti-rabbit IgG antibody (Molecular Probes, Eugene
OR); biotinylated anti-sheep IgG (Vector Laboratories, Burlingame,
CA); anti-FLAG mAb (Sigma, woodlands, USA); anti-myc pAb and
anti-GFP-mAb (Santa Cruz, Santa Cruz, CA); HRP-conjugated
anti-sheep IgG (Jackson ImmunoResearch Laboratories Inc., West
Grove, PA); and HRP-conjugated anti-mouse IgG and HRP-
conjugated anti-rabbit IgG antibody (Cell Signaling Technology,
Beverly, MA). Tunicamycin was obtained from Sigma.
Cell culture and induction of ER stress
SK-N-SH human neuroblastoma cells were obtained from the
Riken Cell Bank (Tsukuba, Japan), and were cultured in a-MEM
(Invitrogen) containing 10% fetal bovine serum at 37uC under 5%
CO2. These cells were transfected with pcDNA3.1-hSOD1 and
pcDNA3.1-hL84V-SOD1 to cause overexpression of wild-type or
L84V mutant SOD1, respectively. G418 resistant stable neuro-
blastoma cell lines expressing equal levels of endogenous and
exogenous SOD1 were established. In all experiments, we used
cultures that were at 70–80% confluence to avoid the influence of
stress induced by overgrowth. On the day of stimulation, fresh
medium was added more than 1 h before exposure to stress in
order to ensure the same conditions for each culture.
Western blot analysis
SK-N-SH cells stably expressing wild-type or L84V SOD1 were
washed with PBS, harvested, and lysed in TNE buffer containing
1 mM PMSF and 1% SDS. 10 mg of protein was subjected to 12%
SDS-PAGE and transferred to a PVDF membrane (Millipore
Corp.). The membrane was blocked with 5% skim milk and
incubated with anti-SOD1 antibody (1:1500 dilution), followed by
incubation with an HRP-conjugated secondary antibody. Proteins
were visualized with an ECL detection system (Amersham-
Pharmacia).
Immunocytochemistry
SK-N-SH cells stably expressing wild-type SOD1 or L84V SOD1
were treated with 1 mg/ml of tunicamycin for 24 h. Then the cells
were fixed with Zamboni’s solution (0.1 M phosphate-buffered
saline (PBS; pH 7.4) containing 2% paraformaldehyde (PFA) and
21% picric acid), rinsed in 0.1 M PBS, and incubated for 30 min
in 0.3% H2O2 to eliminate endogenous peroxidases. Next, the
cells were incubated overnight at 4uC with the primary antibody (a
polyclonal sheep anti-SOD1 antibody; Calbiochem) at 1:1000 in
0.1 M PBS containing 0.3% Triton X-100 and 3% bovine serum
albumin (BSA). After washing in 0.1 M PBS, cells were incubated
for 30 min with the secondary antibody (biotinylated anti-sheep
IgG) (Vector Laboratories). After amplification with avidin-biotin
complex from the ABC kit (Vector Laboratories), reaction
products were visualized with 0.05 M Tris-HCl buffer (TBS; pH
7.6) containing 0.02% diaminobenzidine tetrahydrochloride
(DAB) and 0.01% hydrogen peroxide. Finally, the cells were
counterstained with Mayer’s hematoxylin and eosin (HE).
Co-immunoprecipitation assay utilizing ubiquitin
Lysates of pcDNA3.1-myc-tagged ubiquitin (a kind gift from Dr.
Niwa and Prof. Sobue [32])-transfected SK-N-SH cells stably
expressing wild-type SOD1 or L84V SOD1 were prepared using
TNE buffer (10 mM Tris-HCl, (pH 7.4), 150 mM NaCl, and
1 mM EDTA) containing 1 mM phenylmethylsulphonyl fluoride
(PMSF), 2 mg/ml aprotinin, and 1% Nonidet P-40 after treatment
with or without 4 mg/ml ALLN for 12 h. Then, 1 mg of anti-
FLAG antibody was added to 400 mg of lysate, followed by
incubation at 4uC for at least 3 h. Protein G-Sepharose (10 ml gel)
was then added and incubation was done with rotation at 4uC for
1 h. The immunoprecipitate was subjected to SDS-PAGE and
transferred to a polyvinylidene fluoride (PVDF) membrane. The
membrane was blocked with 5% skim milk and then was
incubated with anti-Myc antibody (1:1000 dilution), followed by
incubation with an HRP-conjugated secondary antibody. Proteins
were visualized with an ECL detection system (Amersham-
Pharmacia).
Immunofluorescence and chemifluorescence
SK-N-SH cells expressing wild-type SOD1 or L84V SOD1 were
incubated with or without tunicamycin or ALLN, rinsed in
0.02 M PBS, and fixed in Zamboni’s fixative. Then the cells were
incubated overnight at 4uC with an anti-SOD1 antibody (1:1000
dilution) and either anti-KDEL (1:500 dilution), anti-GM130
(1:500 dilution) or anti-ubiquitin (1:500 dilution) antibody in
0.02 M PBS containing 0.3% Triton X-100 and 3% BSA. Next,
the cells were treated with fluorescent dye (Alexa Fluor 488)-
conjugated donkey anti-sheep IgG (SOD1; 1:1000 dilution),
fluorescent dye (Alexa Fluor 568)-conjugated goat anti-mouse
IgG (KDEL, GM130; 1:1000 dilution), and goat anti-rabbit IgG
(ubiquitin; 1:1000) as the secondary antibodies for 1 h at RT in
0.02 M PBS containing 3% BSA. Examination was done under
a Zeiss LSM 510 microscope. For detection of SOD1 colocaliza-
tion with cytochrome b5, pCMV b5-EGFP vector was transfected
to the cells (kind gift from Dr. Otera and Prof. Mihara; [49]). The
GFP signal was enhanced by anti-GFP antibody staining (1:100).
In order to determine the localization of SOD1 in living cells, SK-
N-SH cells expressing wt and L84V SOD1 were transfected with
a pcDNA3.1-GFP-tagged wt and L84V SOD1 plasmid, re-
spectively. After treatment with tunicamycin for 24 hr, the cells
were further incubated with Mito-tracker or Lyso-tracker
(Molecular Probes) for 30 min to visualize the mitochondria or
lysosomes, respectively. Then the cells were rinsed at least three
times in 0.1 M PBS and fixed with Zamboni’s solution for
examination under a LSM 510 confocal microscope (Zeiss, Osaka,
Japan).
Electron microscopy
SK-N-SH cells stably expressing L84V SOD1 were exposed to
1 mg/ml tunicamycin for 24 h and then fixed at room temperature
(RT) for 1 h in 0.1 M phosphate buffer (PB) containing 2.5%
glutaraldehyde (GA) and 2% paraformaldehyde. Subsequently,
the cells were post-fixed in 1% OsO4 at RT for 1 h, dehydrated in
a graded ethanol series, and embedded in epoxy resin (Quetol 812;
Nisshin EM Co.). Areas containing cells with aggregates were
block-mounted in epoxy resin by the direct epoxy-resin embedding
method and cut into 90-nm sections. The sections were counter-
stained with uranyl acetate and lead citrate, and then examined
using an H-7100 electron microscope (Hitachi).
LBHI/Ast-HI-Like Inclusions
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As with immunocytocemistry methods above, after fixation with
Zamboni solution containing 0.1% GA, the cells with anti-SOD1
antibody were developed with DAB. Then, they were post-fixed in
1% OsO4 in 0.1 M PB at RT for 30 min after 1% GA in 0.1M PB
re-fixation. The samples were dehydrated in a graded ethanol
series and then embedded in Quetol 812. Areas containing cells
with aggregate morphology were block-mounted and cut into 90-
nm sections. The sections were counterstained with uranyl acetate
and lead citrate, and then examined with an H-7100 electron
microscope.
Analysis of inclusion bodies (light microscopy and
electron microscopy)
Sections of SK-N-SH cells containing eosinophilic hyaline
inclusion bodies and spinal cord sections from transgenic SOD1
L84V mice were decolorized, rehydrated, rinsed in 0.1 M PBS,
and then blocked for 1 h in 0.1 M PBS containing 0.3% Triton X-
100 and 3% BSA. Next, the sections were incubated overnight at
4uC with the primary antibody (polyclonal sheep anti-SOD1
antibody at 1:500) in 0.1 M PBS containing 0.3% Triton X-100
and 3% BSA. After washing in 0.1 M PBS, sections were
incubated for 30 min with the secondary antibody (biotinylated
anti-sheep IgG). Subsequently, incubation was performed for
30 min in 3% H2O2 to eliminate endogenous peroxidases. After
amplification with avidin-biotin complex (ABC kit, Vector
Laboratories), visualization of reaction products was done with
0.05 M TBS (pH 7.6) containing 1.25% DAB and 0.75%
hydrogen peroxide.
For electron microscopy, samples of SK-N-SH cells expressing
L84V SOD1 and spinal cords from transgenic SOD1 L84V mice
were decolorized, rehydrated, and rinsed in 0.1 M PBS. The
samples were further fixed and dehydrated. Then the samples
were embedded directly in epoxy resin, sectioned, counterstained,
and examined as described under electron microscopy section.
SUPPORTING INFORMATION
Figure S1 Cytosolic localization of SOD1 in wt SOD1
expressing cells under ER stress. (A-F, A9-F9) Analysis of
localization of SOD1 on ER. WT SOD1-expressing SK-N-SH
cells were incubated for 24 h without (A-F) or with 1 ug/ml of
tunicamycin (A9-F9). Then the cells were fixed and stained using
an anti-SOD1 antibody (green; A, D, A9,D 9) and an anti-KDEL
antibody (red; B, B9) or an anti-GRP78 antibody (red; E, E9). GFP-
cytochrome b5 were transfected to the cells and stained with anti-
GFP (green; G, G9) and anti-SOD1 (red; H, H9) antibodies.
Merged images (C, F, I, C9 F9,I 9). (J-R, J9-R9) Analysis of SOD1
localization to the mitochondria. WT SOD1-expressing SK-N-SH
cells were treated as described in above. The locations of the
mitochondria and SOD1 were visualized in WT SOD1-expressing
SK-N-SH cells using 100 nM Mito-tracker (red; K, K9), an anti-
Tim17 antibody (red; N, N9) or an anti-Tom20 antibody (red; Q,
Q9) and an anti-SOD1 antibody (green; J, M, P, J9,M 9,P 9).
Merged images (L, O, R, L9,O 9,R 9). (S-U, S9-U9) Investigation of
SOD1 localization to the Golgi apparatus. L84V SOD1-expres-
sing SK-N-SH cells were treated as described in above. Then the
cells were stained with anti-SOD1 antibody (green; S, S9) and anti-
GM130 antibody (red; T, T9). Merged images (U, U9). (V-X, V9-
X9) Analysis of the localization of SOD1 to the lysosomes. A GFP-
tagged WT SOD1 vector was transfected into WT SOD1-
expressing SK-N-SH cells. After 24 h of incubation with 1 ug/ml
of tunicamycin, the cells were incubated for a further 30 min with
100 nM Lyso-tracker (red; W, W9) to visualize the lysosomes. GFP
channel (V, V9) Merged images (X, X9). Scale bars=20 um.
Found at: doi:10.1371/journal.pone.0001030.s001 (3.70 MB TIF)
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